These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

630 related items for PubMed ID: 26821625

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y, Wright JT, Samuel R, Zappe D, Purkayastha D, Black HR, EVALUATE study.
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of chlorthalidone and hydrochlorothiazide in combination with amiloride in multiple doses on blood pressure in patients with primary hypertension: a protocol for a factorial randomized controlled trial.
    Martins VM, Helal L, Ferrari F, Bottino LG, Fuchs SC, Fuchs FD.
    Trials; 2019 Dec 16; 20(1):736. PubMed ID: 31843024
    [Abstract] [Full Text] [Related]

  • 4. Antihypertensive effects of two fixed-dose combinations of losartan and hydrochlorothiazide versus hydrochlorothiazide monotherapy in subjects with ambulatory systolic hypertension.
    Lacourcière Y, Poirier L.
    Am J Hypertens; 2003 Dec 16; 16(12):1036-42. PubMed ID: 14643578
    [Abstract] [Full Text] [Related]

  • 5. A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension.
    Cushman WC, Bakris GL, White WB, Weber MA, Sica D, Roberts A, Lloyd E, Kupfer S.
    J Hypertens; 2018 Apr 16; 36(4):947-956. PubMed ID: 29334491
    [Abstract] [Full Text] [Related]

  • 6. Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.
    Duprez D, Ferdinand K, Purkayastha D, Samuel R, Wright R.
    Vasc Health Risk Manag; 2011 Apr 16; 7():701-8. PubMed ID: 22174580
    [Abstract] [Full Text] [Related]

  • 7. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure.
    Ernst ME, Carter BL, Goerdt CJ, Steffensmeier JJ, Phillips BB, Zimmerman MB, Bergus GR.
    Hypertension; 2006 Mar 16; 47(3):352-8. PubMed ID: 16432050
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension.
    Lacourcière Y, Poirier L, Lefebvre J, Archambault F, Cléroux J, Boileau G.
    Am J Hypertens; 1995 Dec 16; 8(12 Pt 1):1154-9. PubMed ID: 8998248
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the efficacy between hydrochlorothiazide and chlorthalidone on central aortic pressure when added on to candesartan in treatment-naïve patients of hypertension.
    Kwon BJ, Jang SW, Choi KY, Kim DB, Cho EJ, Ihm SH, Youn HJ, Kim JH.
    Hypertens Res; 2013 Jan 16; 36(1):79-84. PubMed ID: 23034468
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
    Guthrie R, Reggi DR, Plesher MM, Saini RK, Battikha JP.
    Am J Hypertens; 1996 Apr 16; 9(4 Pt 1):306-11. PubMed ID: 8722432
    [Abstract] [Full Text] [Related]

  • 11. Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: A systematic review and meta-analysis.
    Roush GC, Abdelfattah R, Song S, Ernst ME, Sica DA, Kostis JB.
    J Clin Hypertens (Greenwich); 2018 Oct 16; 20(10):1507-1515. PubMed ID: 30251403
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan 16; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of the efficacy and safety of a hydrochlorothiazide to chlorthalidone medication change in veterans with hypertension.
    Matthews KA, Brenner MJ, Brenner AC.
    Clin Ther; 2013 Sep 16; 35(9):1423-30. PubMed ID: 23993697
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
    Ambrosioni E, Bombelli M, Cerasola G, Cipollone F, Ferri C, Grazioli I, Leprotti C, Mancia G, Melzi G, Mugellini A, Mulè G, Palasciano G, Salvetti A, Trimarco B.
    Adv Ther; 2010 Jun 16; 27(6):365-80. PubMed ID: 20556561
    [Abstract] [Full Text] [Related]

  • 20. Expedited blood pressure control with initial angiotensin II antagonist/diuretic therapy compared with stepped-care therapy in patients with ambulatory systolic hypertension.
    Lacourcière Y, Poirier L, Lefebvre J.
    Can J Cardiol; 2007 Apr 16; 23(5):377-82. PubMed ID: 17440643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.